The company had reported a net profit of Rs 18 crore in the quarter ended June 30, 2008, Merck said in a statement. During the quarter under consideration, the total income of the company stood at Rs 135.39 crore registering an increase of 28 per cent compared to Rs 105.06 crore in the corresponding quarter last year.
23.02.09: MSD India, a wholly-owned subsidiary of US drug maker Merck & Co, plans to hire 300 people this year as it looks to expand its presence in the Indian market, where it intends to introduce more vaccines.
The company plans to introduce vaccines for Rotavirus, Hepatitis A and Herpes in the next two years in the country. The new hirings will be for all areas of its operations, he said, adding the company has identified five segments - oncology, neurology, metabolics, cardio-vascular and critical care - for growth in the country.
0 Response to "MERCK"
Post a Comment